APO Research
Talk to an analyst

APO RESEARCH · REPORT

Melanin Concentrating Hormone Receptor 1

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Melanin Concentrating Hormone Receptor 1 Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchMelanin Concentrating Hormone Receptor 1 Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal Melanin Concentrating Hormone Receptor 1 Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Melanin Concentrating Hormone Receptor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Melanin Concentrating Hormone Receptor 1 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Melanin Concentrating Hormone Receptor 1 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Melanin Concentrating Hormone Receptor 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Melanin Concentrating Hormone Receptor 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Melanin Concentrating Hormone Receptor 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Melanin Concentrating Hormone Receptor 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Melanin Concentrating Hormone Receptor 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Melanin Concentrating Hormone Receptor 1 include Boehringer Ingelheim GmbH, ConSynance Therapeutics Inc, AstraZeneca Plc and Takeda Pharmaceutical Co Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Melanin Concentrating Hormone Receptor 1, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Melanin Concentrating Hormone Receptor 1, also provides the revenue of main regions and countries. Of the upcoming market potential for Melanin Concentrating Hormone Receptor 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Melanin Concentrating Hormone Receptor 1 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Melanin Concentrating Hormone Receptor 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Melanin Concentrating Hormone Receptor 1 revenue, projected growth trends, production technology, application and end-user industry.

Melanin Concentrating Hormone Receptor 1 Segment by Company

Boehringer Ingelheim GmbH

ConSynance Therapeutics Inc

AstraZeneca Plc

Takeda Pharmaceutical Co Ltd

Melanin Concentrating Hormone Receptor 1 Segment by Type

BI-186908

AZD-3857

AZ-13483342

ALB-127158(a)

Others

Melanin Concentrating Hormone Receptor 1 Segment by Application

Inflammatory Bowel Disease

Obesity

Non-Alcoholic Steatohepatitis

Others

Melanin Concentrating Hormone Receptor 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melanin Concentrating Hormone Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melanin Concentrating Hormone Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melanin Concentrating Hormone Receptor 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Melanin Concentrating Hormone Receptor 1 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Melanin Concentrating Hormone Receptor 1 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Melanin Concentrating Hormone Receptor 1 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Melanin Concentrating Hormone Receptor 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BI-186908 Major Player Table 3. AZD-3857 Major Player Table 4. AZ-13483342 Major Player Table 5. ALB-127158(a) Major Player Table 6. Others Major Player Table 7. Global Melanin Concentrating Hormone Receptor 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Inflammatory Bowel Disease Major Player Table 9. Obesity Major Player Table 10. Non-Alcoholic Steatohepatitis Major Player Table 11. Others Major Player Table 12. Melanin Concentrating Hormone Receptor 1 Industry Trends Table 13. Melanin Concentrating Hormone Receptor 1 Industry Drivers Table 14. Melanin Concentrating Hormone Receptor 1 Industry Opportunities and Challenges Table 15. Melanin Concentrating Hormone Receptor 1 Industry Restraints Table 16. Global Melanin Concentrating Hormone Receptor 1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Melanin Concentrating Hormone Receptor 1 Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Melanin Concentrating Hormone Receptor 1 Market Share by Region (2021-2026) Table 19. Global Melanin Concentrating Hormone Receptor 1 Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Melanin Concentrating Hormone Receptor 1 Market Share by Region (2027-2032) Table 21. Global Melanin Concentrating Hormone Receptor 1 Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Players (2021-2026) Table 23. Global Melanin Concentrating Hormone Receptor 1 Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Melanin Concentrating Hormone Receptor 1 Key Players Headquarters & Area Served Table 25. Global Melanin Concentrating Hormone Receptor 1 Players, Product Type & Application Table 26. Global Melanin Concentrating Hormone Receptor 1 Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Melanin Concentrating Hormone Receptor 1 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Melanin Concentrating Hormone Receptor 1 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Type (2021-2026) Table 33. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Type (2027-2032) Table 34. Global Melanin Concentrating Hormone Receptor 1 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Application (2021-2026) Table 38. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Application (2027-2032) Table 39. Boehringer Ingelheim GmbH Company Information Table 40. Boehringer Ingelheim GmbH Business Overview Table 41. Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 43. Boehringer Ingelheim GmbH Recent Development Table 44. ConSynance Therapeutics Inc Company Information Table 45. ConSynance Therapeutics Inc Business Overview Table 46. ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 48. ConSynance Therapeutics Inc Recent Development Table 49. AstraZeneca Plc Company Information Table 50. AstraZeneca Plc Business Overview Table 51. AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 53. AstraZeneca Plc Recent Development Table 54. Takeda Pharmaceutical Co Ltd Company Information Table 55. Takeda Pharmaceutical Co Ltd Business Overview Table 56. Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Product Portfolio Table 58. Takeda Pharmaceutical Co Ltd Recent Development Table 59. North America Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026) & (US$ Million) Table 60. North America Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032) & (US$ Million) Table 61. North America Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026) & (US$ Million) Table 62. North America Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032) & (US$ Million) Table 63. North America Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 64. North America Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021-2026) & (US$ Million) Table 65. North America Melanin Concentrating Hormone Receptor 1 Revenue by Country (US$ Million) & (2027-2032) Table 66. Europe Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026) & (US$ Million) Table 67. Europe Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032) & (US$ Million) Table 68. Europe Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026) & (US$ Million) Table 69. Europe Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032) & (US$ Million) Table 70. Europe Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. Europe Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021-2026) & (US$ Million) Table 72. Europe Melanin Concentrating Hormone Receptor 1 Revenue by Country (US$ Million) & (2027-2032) Table 73. China Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026) & (US$ Million) Table 74. China Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032) & (US$ Million) Table 75. China Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026) & (US$ Million) Table 76. China Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032) & (US$ Million) Table 77. Asia Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026) & (US$ Million) Table 78. Asia Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032) & (US$ Million) Table 79. Asia Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026) & (US$ Million) Table 80. Asia Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032) & (US$ Million) Table 81. Asia Melanin Concentrating Hormone Receptor 1 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Asia Melanin Concentrating Hormone Receptor 1 Revenue by Region (US$ Million) & (2021-2026) Table 83. Asia Melanin Concentrating Hormone Receptor 1 Revenue by Region (US$ Million) & (2027-2032) Table 84. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026) & (US$ Million) Table 85. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032) & (US$ Million) Table 86. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026) & (US$ Million) Table 87. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032) & (US$ Million) Table 88. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021-2026) & (US$ Million) Table 90. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Country (US$ Million) & (2027-2032) Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Melanin Concentrating Hormone Receptor 1 Image Figure 2. Global Melanin Concentrating Hormone Receptor 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melanin Concentrating Hormone Receptor 1 Market Size Share 2021 VS 2025 VS 2032 Figure 4. BI-186908 Image Figure 5. AZD-3857 Image Figure 6. AZ-13483342 Image Figure 7. ALB-127158(a) Image Figure 8. Others Image Figure 9. Global Melanin Concentrating Hormone Receptor 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Melanin Concentrating Hormone Receptor 1 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Inflammatory Bowel Disease Image Figure 12. Obesity Image Figure 13. Non-Alcoholic Steatohepatitis Image Figure 14. Others Image Figure 15. Global Melanin Concentrating Hormone Receptor 1 Market Size (US$ Million) & (2021-2032) Figure 16. Global Melanin Concentrating Hormone Receptor 1 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Melanin Concentrating Hormone Receptor 1 Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Melanin Concentrating Hormone Receptor 1 Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Type (2021-2032) Figure 23. Global Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Application (2021-2032) Figure 26. North America Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032) Figure 28. North America Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032) Figure 29. North America Melanin Concentrating Hormone Receptor 1 Revenue Share by Country (2021-2032) Figure 30. United States Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032) Figure 35. Europe Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032) Figure 36. Europe Melanin Concentrating Hormone Receptor 1 Revenue Share by Country (2021-2032) Figure 37. Germany Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032) Figure 47. China Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032) Figure 48. Asia Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032) Figure 50. Asia Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032) Figure 51. Asia Melanin Concentrating Hormone Receptor 1 Revenue Share by Region (2021-2032) Figure 52. Japan Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032) Figure 60. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032) Figure 61. SAMEA Melanin Concentrating Hormone Receptor 1 Revenue Share by Country (2021-2032) Figure 62. Brazil Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Melanin Concentrating Hormone Receptor 1 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • BI-186908
  • AZD-3857
  • AZ-13483342
  • ALB-127158(a)
  • Others
Applications
  • Inflammatory Bowel Disease
  • Obesity
  • Non-Alcoholic Steatohepatitis
  • Others
Companies covered
  • Boehringer Ingelheim GmbH
  • ConSynance Therapeutics Inc
  • AstraZeneca Plc
  • Takeda Pharmaceutical Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Melanin Concentrating Hormone Receptor 1 Market by Type
  3. 1.2.1 Global Melanin Concentrating Hormone Receptor 1 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BI-186908
  5. 1.2.3 AZD-3857
  6. 1.2.4 AZ-13483342
  7. 1.2.5 ALB-127158(a)
  8. 1.2.6 Others
  9. 1.3 Melanin Concentrating Hormone Receptor 1 Market by Application
  10. 1.3.1 Global Melanin Concentrating Hormone Receptor 1 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Inflammatory Bowel Disease
  12. 1.3.3 Obesity
  13. 1.3.4 Non-Alcoholic Steatohepatitis
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Melanin Concentrating Hormone Receptor 1 Market Dynamics
  1. 2.1 Melanin Concentrating Hormone Receptor 1 Industry Trends
  2. 2.2 Melanin Concentrating Hormone Receptor 1 Industry Drivers
  3. 2.3 Melanin Concentrating Hormone Receptor 1 Industry Opportunities and Challenges
  4. 2.4 Melanin Concentrating Hormone Receptor 1 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Melanin Concentrating Hormone Receptor 1 Market Perspective (2021-2032)
  2. 3.2 Global Melanin Concentrating Hormone Receptor 1 Growth Trends by Region
  3. 3.2.1 Global Melanin Concentrating Hormone Receptor 1 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Melanin Concentrating Hormone Receptor 1 Market Size by Region (2021-2026)
  5. 3.2.3 Global Melanin Concentrating Hormone Receptor 1 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Melanin Concentrating Hormone Receptor 1 Revenue by Players
  2. 4.1.1 Global Melanin Concentrating Hormone Receptor 1 Revenue by Players (2021-2026)
  3. 4.1.2 Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Melanin Concentrating Hormone Receptor 1 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Melanin Concentrating Hormone Receptor 1 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Melanin Concentrating Hormone Receptor 1 Key Players Headquarters & Area Served
  7. 4.4 Global Melanin Concentrating Hormone Receptor 1 Players, Product Type & Application
  8. 4.5 Global Melanin Concentrating Hormone Receptor 1 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Melanin Concentrating Hormone Receptor 1 Market CR5 and HHI
  11. 4.6.3 2025 Melanin Concentrating Hormone Receptor 1 Tier 1, Tier 2, and Tier 3
5 Melanin Concentrating Hormone Receptor 1 Market Size by Type
  1. 5.1 Global Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2032)
  3. 5.3 Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Type (2021-2032)
6 Melanin Concentrating Hormone Receptor 1 Market Size by Application
  1. 6.1 Global Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2032)
  3. 6.3 Global Melanin Concentrating Hormone Receptor 1 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Boehringer Ingelheim GmbH
  2. 7.1.1 Boehringer Ingelheim GmbH Company Information
  3. 7.1.2 Boehringer Ingelheim GmbH Business Overview
  4. 7.1.3 Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim GmbH Melanin Concentrating Hormone Receptor 1 Product Portfolio
  6. 7.1.5 Boehringer Ingelheim GmbH Recent Developments
  7. 7.2 ConSynance Therapeutics Inc
  8. 7.2.1 ConSynance Therapeutics Inc Company Information
  9. 7.2.2 ConSynance Therapeutics Inc Business Overview
  10. 7.2.3 ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ConSynance Therapeutics Inc Melanin Concentrating Hormone Receptor 1 Product Portfolio
  12. 7.2.5 ConSynance Therapeutics Inc Recent Developments
  13. 7.3 AstraZeneca Plc
  14. 7.3.1 AstraZeneca Plc Company Information
  15. 7.3.2 AstraZeneca Plc Business Overview
  16. 7.3.3 AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca Plc Melanin Concentrating Hormone Receptor 1 Product Portfolio
  18. 7.3.5 AstraZeneca Plc Recent Developments
  19. 7.4 Takeda Pharmaceutical Co Ltd
  20. 7.4.1 Takeda Pharmaceutical Co Ltd Company Information
  21. 7.4.2 Takeda Pharmaceutical Co Ltd Business Overview
  22. 7.4.3 Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Takeda Pharmaceutical Co Ltd Melanin Concentrating Hormone Receptor 1 Product Portfolio
  24. 7.4.5 Takeda Pharmaceutical Co Ltd Recent Developments
8 North America
  1. 8.1 North America Melanin Concentrating Hormone Receptor 1 Revenue (2021-2032)
  2. 8.2 North America Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2032)
  3. 8.2.1 North America Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026)
  4. 8.2.2 North America Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032)
  5. 8.3 North America Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032)
  6. 8.4 North America Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2032)
  7. 8.4.1 North America Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026)
  8. 8.4.2 North America Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032)
  9. 8.5 North America Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032)
  10. 8.6 North America Melanin Concentrating Hormone Receptor 1 Revenue by Country
  11. 8.6.1 North America Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021-2026)
  13. 8.6.3 North America Melanin Concentrating Hormone Receptor 1 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Melanin Concentrating Hormone Receptor 1 Revenue (2021-2032)
  2. 9.2 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2032)
  3. 9.2.1 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026)
  4. 9.2.2 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032)
  5. 9.3 Europe Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032)
  6. 9.4 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2032)
  7. 9.4.1 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026)
  8. 9.4.2 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032)
  9. 9.5 Europe Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032)
  10. 9.6 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Country
  11. 9.6.1 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021-2026)
  13. 9.6.3 Europe Melanin Concentrating Hormone Receptor 1 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Melanin Concentrating Hormone Receptor 1 Revenue (2021-2032)
  2. 10.2 China Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2032)
  3. 10.2.1 China Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026)
  4. 10.2.2 China Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032)
  5. 10.3 China Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032)
  6. 10.4 China Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2032)
  7. 10.4.1 China Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026)
  8. 10.4.2 China Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032)
  9. 10.5 China Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Melanin Concentrating Hormone Receptor 1 Revenue (2021-2032)
  2. 11.2 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2032)
  3. 11.2.1 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026)
  4. 11.2.2 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032)
  5. 11.3 Asia Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032)
  6. 11.4 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2032)
  7. 11.4.1 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026)
  8. 11.4.2 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032)
  9. 11.5 Asia Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032)
  10. 11.6 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Country
  11. 11.6.1 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021-2026)
  13. 11.6.3 Asia Melanin Concentrating Hormone Receptor 1 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue (2021-2032)
  2. 12.2 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Type (2027-2032)
  5. 12.3 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Application (2027-2032)
  9. 12.5 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Country
  11. 12.6.1 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Melanin Concentrating Hormone Receptor 1 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst